Alvotech (NASDAQ:ALVOW – Get Free Report)’s share price fell 6.6% on Friday. The stock traded as low as $0.42 and last traded at $0.42. 1,178 shares changed hands during trading, a decline of 74% from the average session volume of 4,545 shares. The stock had previously closed at $0.4496.
Alvotech Price Performance
The stock’s fifty day moving average is $0.36 and its 200-day moving average is $0.27.
About Alvotech
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
Featured Articles
- Five stocks we like better than Alvotech
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
